A New Paradigm for
Treating CNS Diseases

Inhibikase is a clinical-stage specialty pharmaceutical company innovating small-molecule kinase inhibitor therapeutics targeting CNS disease, including diseases of the brain. MORE

Programs focused on reversing the course of neurodegenerative diseases

Programs focused on treating life-threatening brain infections